Navigation Links
TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil
Date:12/10/2007

of patients with CLL and Cephalon expects a review decision from FDA by the end of March 2008. FDA granted orphan drug status for TREANDA for CLL in August 2007, which would entitle Cephalon to a seven-year period of marketing exclusivity for this indication in the United States, if the product is approved.

TREANDA is also being studied for the treatment of patients with indolent non-Hodgkin's lymphoma (NHL) whose disease has progressed during or following treatment with rituximab. The detailed results of this Phase 3 study also were presented during the ASH annual meeting. In addition, Cephalon has studied TREANDA in combination with rituximab in patients with relapsed indolent and mantle cell NHL. Cephalon plans to submit an NDA for TREANDA by the end of 2007 as a single agent for the treatment of patients with indolent NHL whose disease has progressed during or following treatment with rituximab.

Cephalon holds exclusive rights to market and develop TREANDA in the United States. TREANDA is licensed from Astellas Pharma GmbH. Bendamustine HCl, the active ingredient in TREANDA, is marketed in Germany by Astellas' licensee, Mundipharma International Corporation Limited, under the tradename RIBOMUSTIN(R). In Germany, RIBOMUSTIN is indicated as a single-agent or in combination with other anti-cancer agents for indolent NHL, multiple myeloma, and CLL. SymBio Pharmaceuticals Ltd holds exclusive rights to develop and market bendamustine HCl in Japan and selected Asian countries.

About Cephalon Oncology

Cephalon Oncology is a strategic business unit focused on the development and commercialization of oncology products and resources for patients and healthcare providers. The Cephalon Oncology portfolio includes a number of promising investigational and marketed compounds. In addition to TREANDA, the Cephalon Oncology therapeutic portfolio in the United States includes TRISENOX(R) (arsenic trioxide) injection, a product approved in the United Sta
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non-Hodgkins Lymphoma
2. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
3. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
4. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
5. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
6. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
7. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
8. Promising Phase 3 Trial Results Show Novel Biologic Therapy Ustekinumab (CNTO 1275) Significantly Improved Psoriasis
9. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
10. New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy
11. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... Nov. 18, 2014  TransCelerate BioPharma Inc. ... recent manuscript on Risk-Based Monitoring (RBM), " ... Control Measure in Clinical Trials ," in ... & Regulatory Science  (TIRS) journal. Developed by ... Medidata, the manuscript examines the value of ...
(Date:11/18/2014)... 18, 2014 SynCardia Systems, Inc., has been ... for Small Companies presented by the Arizona Technology Council ... The 11th annual Governor,s Celebration of Innovation Awards honor ... . Arizona Governor Jan ... SynCardia was honored for its Freedom® portable driver, which ...
(Date:11/18/2014)... SOUTH EASTON, Mass. , Nov. 18, 2014 ... or the "Company") today announced the installation of ... for independent evaluation and subsequent potential sale. One ... Radoslav Goldman of Georgetown University while ... a leading biotechnology company. In both settings, the ...
Breaking Medicine Technology:TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 2TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 3SynCardia Named Innovator of the Year by the 2014 Governor's Celebration of Innovation Awards for Its Freedom Portable Driver 2SynCardia Named Innovator of the Year by the 2014 Governor's Celebration of Innovation Awards for Its Freedom Portable Driver 3Pressure BioSciences Ships First Two Barozyme HT48 Systems 2Pressure BioSciences Ships First Two Barozyme HT48 Systems 3Pressure BioSciences Ships First Two Barozyme HT48 Systems 4Pressure BioSciences Ships First Two Barozyme HT48 Systems 5
... INCLINE VILLAGE, Nev., June 16, 2011 PDL BioPharma, ... has paid the June 15, 2011, regular quarterly dividend payment of ... of June 8, 2011, the record date. ... of monoclonal antibodies and, by doing so, enabled the discovery of ...
... , Altair Semiconductor ( http://www.altair-semi.com ... footprint,and high performance 4G LTE,chipsets , announced ... dongle developed by AsiaTelco Technologies, achieved,download speeds of ... than,18Mbps in a live over-the-air demonstration requested by ...
Cached Medicine Technology:Altair Semiconductor Successfully Demonstrates its LTE Chipset Speeds and Service for China Mobile Executives 2Altair Semiconductor Successfully Demonstrates its LTE Chipset Speeds and Service for China Mobile Executives 3
(Date:11/21/2014)... Lauderdale, Florida (PRWEB) November 21, 2014 ... for chronic headaches and other jaw-related symptoms, ... patients seeking relief from chronic head pain, neck pain, ... , “This year we have seen a 52% ... treated. Our network of over 300 doctors and their ...
(Date:11/21/2014)... TideStore.com, a leading online store offering many chic clothes ... TideStore Thanksgiving Sales . According to the company’s CEO, ... big discounts. The special offer is valid during Nov. ... discount with this coupon code: thanks. , Visitors can ... win free gifts. TideStore.com has done much market research ...
(Date:11/21/2014)... 21, 2014 RankingBySEO has announced an ... online reputation of lawyers, and the company has named ... the service for lawyers since it receives queries from ... in big numbers. So far, the company has successfully ... firms in different parts of the world, and now, ...
(Date:11/21/2014)... London, UK (PRWEB) November 21, 2014 ... only ISO verified healthcare professional panel, today announced two important ... appointment of Roni DasGupta as President of Market Research, Americas ... Market Research, Europe. , Ms. DasGupta joined M3 ... President and most recently Head of Sales. Roni has ...
(Date:11/21/2014)... 2014 (HealthDay News) -- Some people with cochlear implants ... magnet when they undergo an MRI scan, a new ... the researchers, about 300,000 people worldwide have cochlear implants, ... who are deaf or have severe hearing loss. There ... cochlear implants when undergoing MRI. One expert said ...
Breaking Medicine News(10 mins):Health News:National Rise In Patients Seeking Headache Relief 2Health News:Thanksgiving Sales from TideStore.com 2Health News:RankingBySEO Announces Lawyer Reputation Management Service 2Health News:M3 Global Research Announces Leadership Team Promotions in US and EU 2Health News:MRI Can Be Painful, Disruptive for People With Cochlear Implants 2
... Riley, a 33-year veteran of the electronic payments processing ... vice president of sales, the company announced today. , ... of PHT,s innovative payment solution for the medical industry ... health care providers to dramatically increase collections and reduce ...
... , HOUSTON, June 24 , , , , ... five on Bioko Island , 57 percent decline ... Bioko Island , 86 percent decline in anemia ... , , , Marathon Oil Corporation ...
... ROSH HAAYIN, Israel, June 24 ... Stock Exchange: PNTR) - a leading,developer, manufacturer and ... Vehicle Location) solutions for stolen vehicle retrieval,fleet management, ... management,and a leading provider of RSA (Road Side ...
... , , CARROLLTON, Ga., June 24 In ... technology (HIT) adoption within the Buffalo, N.Y. region, Greenway ... work with regional health information organizations (RHIOs), health information ... organizations to provide preferred pricing structures for these groups. ...
... 2009) For Professor Chad Mirkin, good things come ... meter in size. Yet, as director of Northwestern University,s ... is anything but small. A prolific inventor and entrepreneur, ... of medical diagnostics and patient point-of-care and to ignite ...
... Award Winners Demonstrates Strong Employer Commitment , to Workplace Health ... The National Business Group on Health (NBGH) is ... spectrum of the U.S. economy -- have been recognized as ... for their exceptional commitment to a healthy workplace and for ...
Cached Medicine News:Health News:PHT Names VP to Lead Sales of A-Claim Payment Solution for Doctors, Hospitals 2Health News:Marathon and Partners Announce Dramatic Results of Malaria Control Project on Bioko Island in Equatorial Guinea 2Health News:Marathon and Partners Announce Dramatic Results of Malaria Control Project on Bioko Island in Equatorial Guinea 3Health News:Marathon and Partners Announce Dramatic Results of Malaria Control Project on Bioko Island in Equatorial Guinea 4Health News:Marathon and Partners Announce Dramatic Results of Malaria Control Project on Bioko Island in Equatorial Guinea 5Health News:Marathon and Partners Announce Dramatic Results of Malaria Control Project on Bioko Island in Equatorial Guinea 6Health News:Pointer Announces Negotiations by Shagrir for Formation of a Joint Venture With a Third Party for the Provision of Services to Insurance Companies in the Field of Dental Care 2Health News:Greenway Medical Technologies Supports Community-Based Interoperability Efforts by Offering Preferred Rates to Buffalo, N.Y. Area Community Healthcare Organizations 2Health News:Greenway Medical Technologies Supports Community-Based Interoperability Efforts by Offering Preferred Rates to Buffalo, N.Y. Area Community Healthcare Organizations 3Health News:World-renowned nanotechnology expert proves there is big potential in the smallest of matter 2Health News:World-renowned nanotechnology expert proves there is big potential in the smallest of matter 3Health News:World-renowned nanotechnology expert proves there is big potential in the smallest of matter 4Health News:National Business Group on Health Recognizes 63 Large Employers as '2009 Best Employers for Healthy Lifestyles' Award Winners 2Health News:National Business Group on Health Recognizes 63 Large Employers as '2009 Best Employers for Healthy Lifestyles' Award Winners 3
... chairs with concave seats and standard-sized ... options like seats, backrests, armrests, and ... are recommended for the following environments: ... control, health care and office. • ...
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTC/1Q chairs are recommended for ... clean room, static control, health care ...
... chairs with concave seats and ... • Select options like seats, ... glides. • BTT/1P chairs are ... industry, education, laboratory, clean room, ...
... concave seats and standard-sized backrests with ... seats, backrests, armrests, and casters and ... for the following environments: industry, education, ... care and office. • With tubular ...
Medicine Products: